Medical Journals

Intrinsic Fak Activity and Y925 Phosphorylation Facilitate an Angiogenic Switch in Tumors.

Authors:
  • Mitra S K
  • Mikolon D
  • Molina J E
  • Hsia D A
  • Hanson D A
  • Chi A
  • Lim S-T
  • Bernard-Trifilo J A
  • Ilic D
  • Stupack D G
  • Cheresh D A
  • Schlaepfer D D

From: Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037, USA.

Oncogene

  • Publish Date: Sep 2006
  • ISSN: 0950-9232
  • Volume: 25
  • Issue: 44
  • Pages: 5969-84
  • Medium: Print
  • Language: English
  • Citation (JAMA): Mitra S K, Mikolon D, Molina J E, et al. Intrinsic Fak Activity and Y925 Phosphorylation Facilitate an Angiogenic Switch in Tumors.. Oncogene Sep 2006;25:5969-84

Abstract

Elevated focal adhesion kinase (FAK) expression occurs in advanced cancers, yet a signaling role for FAK in tumor progression remains undefined. Here, we suppressed FAK activity in 4T1 breast carcinoma cells resulting in reduced FAK Y925 phosphorylation, Grb2 adaptor protein binding to FAK, and signaling to mitogen-activated protein (MAP) kinase (MAPK). Loss of a FAK-Grb2-MAPK linkage did not affect 4T1 cell proliferation or survival in culture, yet FAK inhibition reduced vascular endothelial growth factor (VEGF) expression and resulted in small avascular tumors in mice. This FAK-Grb2-MAPK linkage was essential in promoting angiogenesis as reconstitution experiments using Src-transformed FAK-null fibroblasts revealed that point mutations affecting FAK catalytic activity (R454) or Y925 phosphorylation (F925) disrupted the ability of FAK to promote MAPK- and VEGF-associated tumor growth. Notably, in both FAK-inhibited 4T1 and Src-transformed FAK-null cells, constitutively activated (CA) mitogen-activated protein kinase kinase 1 (MEK1) restored VEGF production and CA-MEK1 or added VEGF rescued tumor growth and angiogenesis. These studies provide the first biological support for Y925 FAK phosphorylation and define a novel role for FAK activity in promoting a MAPK-associated angiogenic switch during tumor progression.

Mesh Headings (Keywords): Animals, Breast Neoplasms, Carcinoma, Cell Line, Transformed, Cell Line, Tumor, Cells, Cultured, Clone Cells, Female, Focal Adhesion Protein-Tyrosine Kinases, Humans, Mammary Neoplasms, Animal, Mice, Mice, Inbred BALB C, Mice, Nude, Neovascularization, Pathologic, Phosphorylation, Protein-Tyrosine Kinases, Signal Transduction, Tyrosine


Check for Full Text / PubMed Unique Identifier (PMID): 16682956


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.